SCYNEXIS Stock Forecast, Price & News

SCYNEXIS (NASDAQ:SCYX) Frequently Asked Questions

Is SCYNEXIS a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SCYNEXIS in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SCYNEXIS stock.
View analyst ratings for SCYNEXIS or view top-rated stocks.

How has SCYNEXIS's stock been impacted by COVID-19 (Coronavirus)?

SCYNEXIS's stock was trading at $7.8020 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SCYX stock has decreased by 19.5% and is now trading at $6.28.
View which stocks have been most impacted by COVID-19.

When is SCYNEXIS's next earnings date?

SCYNEXIS is scheduled to release its next quarterly earnings announcement on Monday, April 4th 2022.
View our earnings forecast for SCYNEXIS.

How were SCYNEXIS's earnings last quarter?

SCYNEXIS, Inc. (NASDAQ:SCYX) announced its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.06) EPS for the quarter, beating analysts' consensus estimates of ($0.79) by $0.73. During the same period last year, the firm posted ($0.28) EPS.
View SCYNEXIS's earnings history.

When did SCYNEXIS's stock split? How did SCYNEXIS's stock split work?

SCYNEXIS shares reverse split on the morning of Friday, July 17th 2020. The 1-10 reverse split was announced on Thursday, July 16th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, July 16th 2020. An investor that had 100 shares of SCYNEXIS stock prior to the reverse split would have 10 shares after the split.

What price target have analysts set for SCYX?

6 Wall Street analysts have issued twelve-month target prices for SCYNEXIS's shares. Their forecasts range from $20.00 to $35.00. On average, they anticipate SCYNEXIS's share price to reach $26.40 in the next twelve months. This suggests a possible upside of 320.4% from the stock's current price.
View analysts' price targets for SCYNEXIS or view top-rated stocks among Wall Street analysts.

Who are SCYNEXIS's key executives?

SCYNEXIS's management team includes the following people:

• Marco Taglietti, President, Chief Executive Officer & Director
• Eric Francois, Chief Financial Officer
• David Angulo Gonzalez, Chief Medical Officer
• Rajeshwar Motheram, SVP-Pharmaceutical Development & Supply Chain
• Nkechi Azie, VP-Clinical Development & Medical Affairs

Who are some of SCYNEXIS's key competitors?

Some companies that are related to SCYNEXIS include Theravance Biopharma (TBPH), Fulcrum Therapeutics (FULC), Vera Therapeutics (VERA), SIGA Technologies (SIGA), Phathom Pharmaceuticals (PHAT), Applied Molecular Transport (AMTI), Arbutus Biopharma (ABUS), Inventiva (IVA), DiaMedica Therapeutics (DMCAF), OrganiGram (OGI), Enochian Biosciences (ENOB), ESSA Pharma (EPIX), Karyopharm Therapeutics (KPTI), ORIC Pharmaceuticals (ORIC) and Veru (VERU).
View all of SCYX's competitors.

What other stocks do shareholders of SCYNEXIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SCYNEXIS investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Sorrento Therapeutics (SRNE), Gran Tierra Energy (GTE), KushCo (KSHB), Zosano Pharma (ZSAN), Bionano Genomics (BNGO), Outlook Therapeutics (OTLK), Cogent Biosciences (UMRX) and Aeterna Zentaris (AEZS).

What is SCYNEXIS's stock symbol?

SCYNEXIS trades on the NASDAQ under the ticker symbol "SCYX."

Who are SCYNEXIS's major shareholders?

SCYNEXIS's stock is owned by many different institutional and retail investors. Top institutional investors include Caxton Corp (6.74%), AIGH Capital Management LLC (1.48%), BlackRock Inc. (1.40%), Two Sigma Advisers LP (1.03%), Geode Capital Management LLC (0.69%) and Telemetry Investments L.L.C. (0.61%). Company insiders that own SCYNEXIS stock include Brian Philippe Tinmouth, Eric Francois, Marco Taglietti, Perceptive Advisors Llc and Scott Sukenick.
View institutional ownership trends for SCYNEXIS.

Which major investors are selling SCYNEXIS stock?

SCYX stock was sold by a variety of institutional investors in the last quarter, including AIGH Capital Management LLC, Two Sigma Investments LP, Two Sigma Advisers LP, Citadel Advisors LLC, GSA Capital Partners LLP, Geode Capital Management LLC, and BlackRock Inc..
View insider buying and selling activity for SCYNEXIS or view top insider-selling stocks.

Which major investors are buying SCYNEXIS stock?

SCYX stock was purchased by a variety of institutional investors in the last quarter, including Brandywine Global Investment Management LLC, Caxton Corp, Altium Capital Management LP, Bank of New York Mellon Corp, Morgan Stanley, Private Advisor Group LLC, Telemetry Investments L.L.C., and Stonepine Capital Management LLC. Company insiders that have bought SCYNEXIS stock in the last two years include Brian Philippe Tinmouth, Eric Francois, Marco Taglietti, and Scott Sukenick.
View insider buying and selling activity for SCYNEXIS or or view top insider-buying stocks.

How do I buy shares of SCYNEXIS?

Shares of SCYX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SCYNEXIS's stock price today?

One share of SCYX stock can currently be purchased for approximately $6.28.

How much money does SCYNEXIS make?

SCYNEXIS has a market capitalization of $150.41 million and generates $120 thousand in revenue each year. The company earns $-55.19 million in net income (profit) each year or ($4.43) on an earnings per share basis.

How many employees does SCYNEXIS have?

SCYNEXIS employs 38 workers across the globe.

What is SCYNEXIS's official website?

The official website for SCYNEXIS is www.scynexis.com.

Where are SCYNEXIS's headquarters?

SCYNEXIS is headquartered at 1 EVERTRUST PLAZA 13TH FLOOR, JERSEY CITY NJ, 07302.

How can I contact SCYNEXIS?

SCYNEXIS's mailing address is 1 EVERTRUST PLAZA 13TH FLOOR, JERSEY CITY NJ, 07302. The company can be reached via phone at (201) 884-5485, via email at [email protected], or via fax at 201-884-5490.